Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcellx (ACLX) Tax Rate (2023 - 2025)

Arcellx's quarterly Tax Rate came in at 0.07% in Q4 2025, up 323.0% year-on-year from 0.02% in Q4 2024, and down 25.27% quarter-over-quarter from 0.05% in Q2 2025.

Arcellx has reported Tax Rate for 3 years, with the latest figure at 0.07% in Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate rose 323.0% year-over-year to 0.07%; the trailing twelve-month figure through Dec 2025 stood at 0.03% (up 187.0% YoY), and the FY2025 full-year result was 0.03%, up 194.0% from the prior year.
  • Tax Rate for Q4 2025 stood at 0.07%, down from 0.05% in the prior quarter.
  • The five-year high for Tax Rate was 3.04% in Q4 2023, with the low at 3.3% in Q4 2024.
  • Average Tax Rate over 3 years is 0.26%, with a median of 0.07% recorded in 2025.
  • Year-over-year, Tax Rate slumped 634 bps in 2024 and surged 323 bps in 2025.
  • Tracing ACLX's Tax Rate over 3 years: stood at 3.04% in 2023, then plunged by 209 bps to 3.3% in 2024, then jumped by 98 bps to 0.07% in 2025.
  • The last three Tax Rate figures came in at 0.07% (Q4 2025), 0.05% (Q2 2025), and 3.3% (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 57.14
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 5.61
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.68
7 Evaxion A 62.56 Bn 62.54 Bn - -6.79
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.51
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7.07
10 Arcellx 6.48 Bn 6.48 Bn - -0.07

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -0.07
Dec 31, 2025 -0.07
Jun 30, 2025 -0.05
Jun 30, 2025 -0.05
Dec 31, 2024 -3.30
Dec 31, 2024 -3.30
Sep 30, 2024 -0.78
Sep 30, 2024 -0.78
Jun 30, 2024 -1.12
Jun 30, 2024 -1.12
Dec 31, 2023 3.04
Dec 31, 2023 3.04
Sep 30, 2023 0.02
Sep 30, 2023 0.02
Jun 30, 2023 1.17
Jun 30, 2023 1.17
Mar 31, 2023 -1.22
Mar 31, 2023 -1.22